The global market size for cell line development market was USD 4.17 billion in 2022 and is projected to reach USD 12.53 billion by 2032, with an anticipated revenue Compound Annual Growth Rate (CAGR) of 13% throughout the forecast period. The development of cell lines is a crucial process in the production of biopharmaceuticals, facilitating the mass production of therapeutic proteins and antibodies. The application of recombinant DNA technology in cell line development has paved the way for the creation of advanced and efficient solutions, enabling the production of high-quality biopharmaceuticals. The biopharmaceutical industry’s increasing reliance on single-use technology is further propelling the demand for cell line creation solutions.
Moreover, the expanding use of Cell-based Assays in drug discovery and development is contributing to the demand for effective and reliable cell line creation solutions. As the adoption of personalized medicine grows, driven by the desire for patient-specific medicines, there is an increasing need for dependable cell line development solutions. This trend is accentuated by the ability of cell-based tests to identify prospective therapeutic candidates with greater precision and specificity.
Request a sample report of Cell Line Development Market @ https://www.reportsanddata.com/download-free-sample/7853
The cell line development market revenue growth is due to the growing emphasis on research and development activities in the sector of biopharmaceuticals. The need for cell line development services is being driven by the need for effective and dependable cell line development solutions for the creation of innovative biopharmaceuticals. The market revenue growth is a result of growing usage of gene editing technologies, such as CRISPR-Cas9, in the creation of cell lines.
Strategic Development:
- In 2021, Exosomics Siena S.p.A. and Lonza Group Ltd. launched a strategic agreement to create exosomes for medicinal and diagnostic purposes. The goal of the partnership was to bring together Exosomics Siena’s expertise in exosome separation and characterization with Lonza’s competence in cell line production.
- In 2020, Qiagen N.V., a business that specializes in sample and assay technology for molecular diagnostics and research, was acquired by Thermo Fisher Scientific Inc. Thermo Fisher wanted to increase the range of products it offered in the cell line development sector, thus it made the acquisition.
- WuXi AppTec Group and Aragen Bioscience Inc. formed a partnership in 2020 to produce cell lines for biotherapeutic drug research. The collaboration aims to combine Aragen’s bioassay development know-how with WuXi’s capabilities in cell line development.
- In 2020, Iktos, a French biotech startup that specializes in using artificial intelligence for drug discovery, and Merck KGaA formed a partnership. The collaboration’s goal was to use AI to hasten the generation of cell lines for the manufacturing of biopharmaceuticals.
Key Players covered in this report are
- Lonza Group Ltd.
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich Corporation
- General Electric Company
- Sartorius AG
- Merck KGaA
- Danaher Corporation
- Corning Incorporated
- WuXi AppTec Group
- Selexis SA
Market Segmentation
| By Product Type Outlook |
|
| By Source Outlook |
|
| By Application Outlook |
|
Read the full report @ https://www.reportsanddata.com/report-detail/cell-line-development-market
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Major Points covered in this report are as below:
- An analysis of Cell Line Development industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
- In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
- In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
- This report provides information on the market status of Cell Line Development manufacturers and provides valuable insight into the market for companies and individuals.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/7853
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
Browse More Reports:
Oxygen Market @ https://www.reportsanddata.com/report-detail/oxygen-market
Exanthema Market @ https://www.reportsanddata.com/report-detail/exanthema-market
Chronic Kidney Diseases Market @ https://www.reportsanddata.com/report-detail/chronic-kidney-diseases-market
Acquired Immunodeficiency Syndrome Market @ https://www.reportsanddata.com/report-detail/acquired-immunodeficiency-syndrome-market
Benzoyl Peroxide Market @ https://www.reportsanddata.com/report-detail/benzoyl-peroxide-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report